News
Dr Barbara Morera Presents at French Network fo...
Dr Barbara Morera, Chief Research Officer at Neupulse, recently delivered an inspiring presentation at the 17th annual meeting of the French Network for Tourette Syndrome. Dr Morera highlighted Neupulse's journey from...
Dr Barbara Morera Presents at French Network fo...
Dr Barbara Morera, Chief Research Officer at Neupulse, recently delivered an inspiring presentation at the 17th annual meeting of the French Network for Tourette Syndrome. Dr Morera highlighted Neupulse's journey from...
Neupulse secures more funding to advance world’...
Neupulse has secured more funding to advance the world’s first wearable device aimed at tackling Tourette Syndrome (TS) and other tic disorders towards commercialisation through the Midlands Engine Investment Fund II,...
Neupulse secures more funding to advance world’...
Neupulse has secured more funding to advance the world’s first wearable device aimed at tackling Tourette Syndrome (TS) and other tic disorders towards commercialisation through the Midlands Engine Investment Fund II,...
Move for Tourette’s 2024 Challenge
We are thrilled to have participated in the Move for Tourette’s 2024 challenge! Our team completed a 10K walk around the beautiful Wollaton Park in Nottingham, all in support of...
Move for Tourette’s 2024 Challenge
We are thrilled to have participated in the Move for Tourette’s 2024 challenge! Our team completed a 10K walk around the beautiful Wollaton Park in Nottingham, all in support of...
Neupulse celebrates recognition at the Medilink...
It was an extraordinary evening for Neupulse on the 9th May as our team had the pleasure of attending the distinguished Medilink Midlands awards. We were honoured to be nominated...
Neupulse celebrates recognition at the Medilink...
It was an extraordinary evening for Neupulse on the 9th May as our team had the pleasure of attending the distinguished Medilink Midlands awards. We were honoured to be nominated...
Neupulse is nominated in 4 categories at the Me...
We are delighted to be nominated for 4 awards at the Medilink awards to be held on 9 May. The awards are designed to recognise and celebrate the best of...
Neupulse is nominated in 4 categories at the Me...
We are delighted to be nominated for 4 awards at the Medilink awards to be held on 9 May. The awards are designed to recognise and celebrate the best of...
Neupulse secures funding to advance world’s fir...
Neupulse has secured funding to advance the world’s first wearable device aimed at tackling Tourettes Syndrome (TS) and other tic disorders towards commercialisation. Neupulse’s recently finalised working prototype stimulates the...
Neupulse secures funding to advance world’s fir...
Neupulse has secured funding to advance the world’s first wearable device aimed at tackling Tourettes Syndrome (TS) and other tic disorders towards commercialisation. Neupulse’s recently finalised working prototype stimulates the...